Lyon, France Saturday, April 28, 2012, 10:00 Hrs [IST] |
|
Sanofi Pasteur, the vaccines division of
Sanofi, announced that the Japanese Ministry of Health, Labor and
Welfare (MHLW) has approved the company’s standalone Inactivated
Poliovirus Vaccine (IPV) against acute flaccid poliomyelitis (Imovax
Polio). Imovax Polio will be added to the country’s public immunization
programme on September 1.
Continue reading pharmabiz.com
|